Skip to main content
. 2022 Jun 30;16(6):1004–1013. doi: 10.1111/irv.13024

TABLE 2.

Estimated overall seroprevalence and corresponding percentages of COVID‐19 vaccinations and confirmed COVID‐19 cases by county of residence

County a Positive samples Number of samples tested (%) Positive samples (all ages), % (95% CI) Estimated seroprevalence (all ages), % (95% credible interval) Positive samples (age ≥18 yrs), % (95% CI) Estimated seroprevalence (age ≥18 yrs), % (95% credible interval) Percentage of the population vaccinated with the first dose of COVID‐19 vaccine (age ≥18 yrs) b Percentage of the population with confirmed COVID‐19 (age ≥18 yrs) c
Oslo 71 115 (6.0) 61.7 (52.2–70.6) 63.2 (54.2–71.9) 78.2 (68.0–86.3) 79.8 (70.0–88.5) 80.9 5.0
Rogaland 76 123 (6.4) 61.8 (52.6–70.4) 63.3 (54.3–72.0) 77.2 (66.4–85.9) 78.8 (69.0–87.7) 66.5 1.5
Møre og Romsdal 80 130 (6.7) 61.5 (52.6–69.9) 63.1 (54.1–71.8) 74.2 (68.5–79.3) 76.1 (70.4–81.5) 64.0 0.7
Nordland 62 126 (6.5) 49.2 (40.2–58.3) 50.6 (42.0–59.7) 61.7 (53.5–69.4) 63.2 (55.2–71.0) 63.3 0.6
Viken 222 390 (20.2) 56.9 (51.8–61.9) 58.4 (53.4–63.5) 67.0 (56.6–76.4) 68.5 (58.7–77.5) 80.8 3.4
Innlandet 66 121 (6.3) 54.5 (45.2–63.6) 56.1 (47.0–65.1) 70.9 (63.3–77.7) 72.7 (65.5–79.8) 65.9 1.5
Vestfold og Telemark 58 125 (6.5) 46.4 (37.4–55.5) 47.6 (38.8–56.5) 67.4 (56.7–77.0) 68.9 (58.6–78.5) 73.6 2.0
Agder 50 113 (5.9) 44.2 (34.9–53.9) 45.6 (36.4–55.0) 76.5 (66.9–84.5) 78.2 (68.8–86.6) 68.7 1.7
Vestland 124 246 (12.8) 50.4 (44.0–56.8) 51.8 (45.5–58.1) 73.9 (66.1–80.6) 75.7 (68.0–82.8) 70.2 1.5
Trøndelag 116 216 (11.2) 53.7 (46.8–60.5) 55.1 (47.9–61.9) 70.4 (59.2–80.0) 71.8 (61.3–81.6) 67.3 1.1
Troms og Finnmark 103 218 (113) 472 (405–541) 486 (417–554) 590 (473–700) 603 (494–711) 62.1 1.0
Missing 1 3 (0.2) 33.3 (0.8–90.6) n.a d 50.0 (1.3–98.7) n.a. n.a. n.a.
a

8 sera were attributed to the county of the submitting laboratory as these sera did not have information on county of residence.

b

Data from SYSVAK, vaccinations by 15 July 2021.

c

Data from Beredt C19, confirmed COVID‐19 cases by 15 July 2021.

d

n.a.: not applicable. Seroprevalence was not estimated for subgroups with less than 30 samples.